[HTML][HTML] Advances with metal oxide-based nanoparticles as MDR metastatic breast cancer therapeutics and diagnostics

MA Subhan - RSC advances, 2022 - pubs.rsc.org
Metal oxide nanoparticles have attracted increased attention due to their emerging
applications in cancer detection and therapy. This study envisioned to highlight the great …

Advances with metal oxide-based nanoparticles as MDR metastatic breast cancer therapeutics and diagnostics

MA Subhan - RSC advances, 2022 - pubmed.ncbi.nlm.nih.gov
Metal oxide nanoparticles have attracted increased attention due to their emerging
applications in cancer detection and therapy. This study envisioned to highlight the great …

Advances with metal oxide-based nanoparticles as MDR metastatic breast cancer therapeutics and diagnostics

M Subhan - RSC Advances, 2022 - europepmc.org
Metal oxide nanoparticles have attracted increased attention due to their emerging
applications in cancer detection and therapy. This study envisioned to highlight the great …

Advances with metal oxide-based nanoparticles as MDR metastatic breast cancer therapeutics and diagnostics

MA Subhan - RSC Advances, 2022 - Elsevier
Metal oxide nanoparticles have attracted increased attention due to their emerging
applications in cancer detection and therapy. This study envisioned to highlight the great …

Advances with metal oxide-based nanoparticles as MDR metastatic breast cancer therapeutics and diagnostics

MA Subhan - RSC Advances, 2022 - ui.adsabs.harvard.edu
Biomarker targeted therapy approaches for TNBC using metal oxide-based NPs are highly
effective and promising. Metal oxide nanoparticles have attracted increased attention due to …

[HTML][HTML] Advances with metal oxide-based nanoparticles as MDR metastatic breast cancer therapeutics and diagnostics

MA Subhan - RSC Advances, 2022 - ncbi.nlm.nih.gov
Metal oxide nanoparticles have attracted increased attention due to their emerging
applications in cancer detection and therapy. This study envisioned to highlight the great …

Advances with metal oxide-based nanoparticles as MDR metastatic breast cancer therapeutics and diagnostics.

MA Subhan - RSC Advances, 2022 - europepmc.org
Metal oxide nanoparticles have attracted increased attention due to their emerging
applications in cancer detection and therapy. This study envisioned to highlight the great …